American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

CVS Health stock price rises after Walgreens earnings: is it a buy?

by admin January 13, 2025
January 13, 2025
CVS Health stock price rises after Walgreens earnings: is it a buy?

The CVS Health stock price rebounded to $48 on Monday, up 10% from its lowest in December. This rebound continued after the strong Walgreens Boots Alliance earnings, which pushed the stock up almost 50% from its lowest point in 2024. So, is the CVS stock a bargain at the current levels?

Walgreens Boots Alliance earnings

The main catalyst for the CVS Health stock price has been the ongoing developments at Walgreens, its biggest competitor in the United States. 

Walgreens stock has risen after reports emerged that it was exploring a sale to Sycamore Partners, a leading player in the private equity industry. Such a deal would mark a big step for a company that was recently a blue-chip Dow Jones index member.

Walgreens then published better-than-expected results, showing that its revenue rose by 7.5% in Q1 ’25 to $39.45 billion. It closed 67 stores during the quarter and is on track to close about 450 more.  

The management warned that the retail sector remained in a rough environment, which will impact its total sales. One reason for this weakness is the flu season, which was weaker than expected. That warning will also translate to CVS Health since the two companies have a near similar business model. 

CVS Health earnings ahead

The developments at Walgreens Boots Alliance will impact CVS’s business ahead of its next earnings scheduled on February 12 this year.

The most recent results showed that CVS Health’s revenue rose by 6.3% in the third quarter to $95.4 billion. However, its operating income dropped to $2.55 billion from $4.46 billion, and its earnings per share fell from $1.75 to $0.07.

Analysts estimate the next quarter’s revenue will be $97 billion, a 3.43% increase from the same quarter a year ago. The highest estimate is $98.97 billion, while the lowest is about $95 billion. 

The company’s annual revenue estimate is $371 billion, a 3.8% increase from the previous year. It will then make $386 billion in the next financial year.

The main challenge for CVS Health and Walgreens is its profitability as restructuring and labor costs rise. Analysts expect that its annual earnings per share will drop from $8.74 to $5.87. Just last quarter, its EPS dropped to $1.09 from $2.21 in the same period last year. 

The other catalyst for the CVS Health stock price will be its strategy this year. One idea is whether management will opt to continue with its current business strategy or spin off its insurance business. 

A spin-off would mark a big change for the company since it acquired Aetna for over $67 billion a few years ago. Today, the combined company is worth about $60.42 billion, meaning that Aetna would have a significantly small valuation. However, there are chances that investors would push the CVS stock price higher if the spin-off was announced, as it would leave a lean and profitable company.

Read more: Here’s why the CVS Health stock price may rebound in 2025

CVS Health stock price analysis

CVS chart by TradingView

The weekly chart shows that the CVS Health share price has continued its strong downward trend in the past few months. It crashed from a high of $101.65 in February 2022 to $44 in December. 

The stock has formed a series of lower lows and lower highs. Most recently, it dropped below the important support at $51.78, its lowest swing in May last year. It remains below the 50-week and 100-week moving averages. 

Therefore, the outlook for the CVS share price is bearish as long as it is below the 50-week moving average and the key resistance point at $51.78.

The post CVS Health stock price rises after Walgreens earnings: is it a buy? appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Here’s why the Zimbabwe ZiG currency has stabilized
next post
Tron price prediction: where technicals meet good fundamentals

Related Posts

Are dividend ETFs like QYLD, XYLD, and SPYI...

October 22, 2024

SoFi stock price technical analysis points to a...

May 15, 2025

License Approvals Received from North-West Territories Regulator for...

February 25, 2024

Awale Resources Limited

February 2, 2024

Li Auto stock price: here’s why this EV...

February 24, 2025

Hang Seng index forms risky pattern as black...

November 4, 2024

Swiss franc, gold, and Bitcoin emerge as safe...

April 22, 2025

Uranium Price Update: Q1 2024 in Review

April 11, 2024

Zodiac Gold

August 5, 2024

Rare Earths Market Update: H1 2024 in Review

August 6, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Interview: Strategic location gives Brazil Potash cost advantage in domestic fertiliser market, says CEO Matt Simpson

      June 1, 2025
    • Canada’s Q1 GDP expands by 2.2%, driven by exports spike ahead of potential US tariffs

      June 1, 2025
    • President Trump to host farewell for Elon Musk as DOGE leader steps away

      June 1, 2025
    • UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

      June 1, 2025
    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025

    Categories

    • Business (3,012)
    • Investing (2,455)
    • Latest News (1,994)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved